CRISIL reaffirms rating assigned to Sandu Pharmaceutical’s bank facilities

05 Mar 2018 Evaluate

The credit rating agency, CRISIL has reaffirmed ‘BB/stable’ rating assigned to Sandu Pharmaceutical’s long term bank facilities. Total bank loan facilities rated are worth Rs 13.35 crore.

Sandu Pharmaceuticals Ltd is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

Sandu Pharmaceutical Share Price

39.50 -0.70 (-1.74%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×